Arteris Lifted 2026 Revenue to $95M-$98M-Now the Stock Has to Prove the Profit Shows Up

Arteris raised the bar on 2026 revenue

Arteris raised its 2026 revenue outlook to $95 million to $98 million, after last reporting record annual contract value plus royalties of $83.6 million. Q2 helped set that tone: the company reported revenue of $24.1 million and exiting ACV plus royalties of $99.5 million, up 44% year over year. The near-term question is no longer whether demand exists, but whether that demand can turn into earnings leverage investors can actually bank.

Why the raised guide matters

The bullish read is straightforward: demand still looks intact, and the business model remains highly asset-light. Arteris posted 85% gross margin in Q2, which suggests the underlying IP still commands a strong economic premium. If demand holds, the new guide becomes a test of execution rather than just a pipeline story.

The bearish read is that the income statement still lags the revenue story. Arteris posted GAAP net loss per share of $0.30, and operating expenses grew faster than gross profit. A higher guide matters only if those costs stop outpacing revenue.

Demand looks real, but investors still need conversion

Arteris said design starts up 21% on a trailing-twelve-month basis, and management said the majority of new designs now include some form of AI compute. That does not guarantee revenue, but it does suggest customer interest is still warming rather than fading.

Why the product fits the current chip cycle

Arteris sells some of the critical plumbing inside chips. Its Network-on-Chip interconnect IP and SoC integration technology help chip makers assemble complex system designs more efficiently, with higher performance, lower power use, and faster time to market. As SoCs become more complex, that role can matter more.

The end-market mix also shows the story is not purely theoretical. Data center chip and chiplet development remains a key growth driver, and enterprise computing averaging 29% of our Annual Contract Value plus royalties over the past four quarters shows that segment is already contributing a meaningful share of activity.

This momentum was building before Q2

The backdrop improved gradually rather than appearing overnight. In May, Arteris raised its full-year 2026 revenue guidance after Q1, which had beaten expectations on both revenue and EPS. That makes the latest guide raise easier to take seriously, but it also increases the burden of proof over the next few quarters.

Profit conversion is the real test

The raised guide shifts the debate from demand to durability. Investors now have to judge whether Arteris can turn stronger design activity into better economics, not just bigger pipeline numbers.

What improved

Gross profit rose 39% to $20.5 million, and quarterly free cash flow turned positive at $8.6 million. Those are constructive signs. They suggest the ramp is producing gross dollars and near-term liquidity, not just announcements.

What still worries investors

Gross margin slipped to 85% from 89%. GAAP net loss per share widened to $0.30 from $0.22. And operating expenses grew faster than gross profit, which is the core concern: revenue is accelerating, but spending is accelerating just as fast.

There is also a leadership watchpoint. The company announced the Chief Financial Officer retired. That does not raise any obvious product or demand concern, but financial discipline during a growth push is usually easier to monitor with a sitting CFO in place.

What has to happen next

For bulls, the next few quarters need to show three things:

• Revenue moves toward the new guide.
• Margins stabilize rather than slip further.
• Spending grows more slowly than gross profit.

If those signals start to line up, the raised guide becomes credible. If not, investors may conclude Arteris is selling more IP without keeping more of it.

What would confirm or invalidate the raise

Arteris is now targeting $95 million to $98 million of 2026 revenue and $102 million to $106 million of 2026 ACV plus royalties. That gives investors roughly two more earnings reports to judge whether the company is converting demand into better operating leverage.

What would confirm it

Another quarter that supports the $102 million to $106 million of 2026 ACV plus royalties target while keeping 85% gross margin and producing cash flow near or better than the Q2 level of $8.6 million of free cash flow would be a strong signal. Together, those metrics would suggest the business is improving, not just expanding.

What would break it

If the next reports show another revenue beat but continued margin pressure and spending that still outruns gross profit, the guide raise may look early. At that point, the debate would shift back from demand to profitability.